by Janet Maker, Ph.D. | Jun 24, 2018 | News
Dr. Brown and his colleagues believe that by putting two and two together, as it were, through the combined findings of all these studies led by the Dana-Farber Cancer Institute, specialists may be able to devise effective treatments for ER-positive breast cancers that don’t respond to endocrine therapy alone. “These results support the potential of this combination as a therapeutic strategy to overcome endocrine resistance caused by the ER mutants,” the researchers suggest.
by Janet Maker, Ph.D. | Jun 24, 2018 | News
Physical therapy could help women get their arm range of motion back much sooner after lymph node dissection compared with simply educating women about the post-surgery effects, according to study results presented during the 2018 Cancer Survivorship Symposium.
by Janet Maker, Ph.D. | Jun 23, 2018 | News
The National Cancer Institute tells everything you need to know about
BRCA
by Janet Maker, Ph.D. | Jun 23, 2018 | News
Cancer warning labels are pretty common in California. A law called Proposition 65 requires stores to provide a “clear and reasonable warning” to customers if their products contain cancer-causing ingredients. Hence this lawsuit, which argues coffee shops aren’t currently following the rules.
by Janet Maker, Ph.D. | Jun 22, 2018 | Surgery
Source: 10-Year Results Show That Many Women Don’t Need Axillary Lymph Node Surgery
by Janet Maker, Ph.D. | Jun 22, 2018 | News
Breast cancer patients may be at an increased risk of cardiovascular diseases including heart failure and may benefit from a treatment approach that weighs the benefits of specific therapies against potential damage to the heart, according to a new scientific statement from the American Heart Association published in its journal Circulation.
by Janet Maker, Ph.D. | Jun 22, 2018 | News
Since the late 1800s, doctors have observed that some patients with cancer go into remission, if only temporarily, after a viral infection. Today, several dozen viruses—and a few strains of bacteria—are being studied as potential cancer treatments, according to research presented at an NCI-sponsored conference on using microbes as cancer therapies in 2017. “Oncolytic virus therapy is of growing interest to researchers for one reason: It’s working,” said Juan Fueyo, M.D., of the University of Texas MD Anderson Cancer Center, who co-developed a type of oncolytic virus being tested in patients with brain tumors.
by Janet Maker, Ph.D. | Jun 21, 2018 | News
Did you know that there are carcinogens lurking throughout your home? From the couch you watch TV on, to curtains, carpets, and even your food, there are many domestic cancer hazards that you need to be aware of in order to stay healthy. Learn all you need to know right here
by Janet Maker, Ph.D. | Jun 20, 2018 | News
The antimicrobial chemical triclosan is in thousands of products that we use daily: hand soaps, toothpastes, body wash, kitchenware and even some toys. Work in our lab suggests that this compound may have widespread health risks, including aggravating inflammation in the gut and promoting the development of colon cancer by altering the gut microbiota, the community of microbes found in our intestines.
by Janet Maker, Ph.D. | Jun 19, 2018 | New Research
A 52-year-old woman from Florida has made history after her advanced metastatic breast cancer was completely treated using a form of personalized immunotherapy Source: Woman Survives “Untreatable” Breast Cancer After Immunotherapy Breakthough |...
by Janet Maker, Ph.D. | Jun 19, 2018 | Chemotherapy
Many women with early-stage forms of the disease can forego chemo, based on a test that measures the activity of genes involved in breast cancer recurrence. Source: Good News for Women With Breast Cancer: Many Don’t Need Chemo – The New York...
by Janet Maker, Ph.D. | Jun 19, 2018 | News
Well, these blogs get it. You’ll find no pity parties here. Instead, you’ll find a collective group of women who often get straight to the nitty-gritty: post-mastectomy life, treatment side effects, breast cancer symptoms, and how to tell your children. You’ll also get plenty of advice on how to manage the disease, from making your bucket list to using alternative therapies like painting to de-stress.
by Janet Maker, Ph.D. | Jun 18, 2018 | News
Human cells resist gene editing by turning on defenses against cancer, ceasing reproduction and sometimes dying, two teams of scientists have found.
by Janet Maker, Ph.D. | Jun 17, 2018 | News
New research published in the journal Aging finds a compound that stops cancer cells from spreading by starving them of vitamin B-2. The findings may revolutionize traditional chemotherapy.
by Janet Maker, Ph.D. | Jun 17, 2018 | News
Gender-bending chemicals found in plastic and linked to breast and prostate cancer are found in 86% of teenagers’ bodies
by Janet Maker, Ph.D. | Jun 16, 2018 | News
After a diagnosis is made, your doctor will stage the cancer. The stage defines the location of the cancer, how much it has spread, how big it is, and how aggressive it is. Knowing the stage of cancer is important because it typically determines your treatment options.
by Janet Maker, Ph.D. | Jun 16, 2018 | News
THE MAJORITY—AROUND 80 PERCENT—OF MEDICAL ONCOLOGISTS said they discuss medical marijuana with patients, according to a study published May 10 in the Journal of Clinical Oncology based on a survey of U.S. oncologists. Nearly half said they had recommended medical marijuana clinically in the past year. But despite this openness, around 70 percent of medical oncologists reported they don’t feel they know enough to make recommendations surrounding medical marijuana use.
by Janet Maker, Ph.D. | Jun 15, 2018 | News
Injecting minute amounts of two immune-stimulating agents directly into solid tumors in mice was able to eliminate all traces of cancer in the animals — including distant, untreated metastases (spreading cancer locations), according to a study by Stanford University School of Medicine researchers. The researchers believe this new “in situ vaccination” method could serve as a rapid and relatively inexpensive cancer therapy — one that is unlikely to cause the adverse side effects often seen with bodywide immune stimulation.
by Janet Maker, Ph.D. | Jun 15, 2018 | News
Thanks to the long-awaited results of a large, NIH-funded clinical trial, we know that about 70 percent of women with hormone receptor (HR)-positive, HER2-negative, axillary lymph node-negative breast cancer—including those with mid-range scores on the cancer recurrence scale—do not benefit from chemotherapy [1]. These findings promise to spare a great many women with breast cancer from unnecessary exposure to costly and potentially toxic chemotherapy.
by Janet Maker, Ph.D. | Jun 14, 2018 | News
A new paper details the regulatory gaps in how the US manages chemicals in food. We explore how failures in our current regulatory system put the public’s health at risk as exemplified in the case of perchlorate, a chemical allowed in food and a well-known endocrine disrupting compound.
